Advanced Delivery Platforms for Therapeutics
Techulon is leading the next generation of disease treatment through development of innovative nucleic acid delivery platforms for cell-based therapeutics. Techulon’s platform technologies are polymer-based nanoparticles that deliver DNA and RNA with lower toxicity and higher expression profiles. The company is focused on delivery for therapeutically relevant cells both locally and systemically. Our team focuses on developing delivery platforms for license by companies bringing new drugs to market. Contact us for more information on opportunities in available fields of use for partnering.